• Applied Workflows with Firefly Luciferase mRNA (ARCA, 5-moUT

  2026-04-19

  Firefly Luciferase mRNA (ARCA, 5-moUTP) from APExBIO sets a new standard for reliable, immune-evasive bioluminescent reporting in gene expression and in vivo imaging. Its advanced modifications empower sensitive assays, robust controls, and streamlined troubleshooting for high-throughput and translational research.

• UBE2F-SAG-Mediated RHEB Neddylation Drives Liver Tumorigenes

  2026-04-18

  This study identifies RHEB as a direct neddylation substrate of the UBE2F-SAG axis, demonstrating that this modification enhances mTORC1 activity and contributes to liver tumorigenesis. These findings illuminate a new regulatory layer in hepatocellular carcinoma and propose the UBE2F-SAG neddylation pathway as a potential therapeutic target.

• Vernakalant Hydrochloride: Rapid AF Conversion and Assay Opt

  2026-04-17

  Vernakalant Hydrochloride (RSD1235) empowers researchers with precise, atrial-selective antiarrhythmic action for fast and reliable atrial fibrillation conversion. This guide translates recent clinical breakthroughs and experimental best practices into actionable workflows, troubleshooting tips, and comparative insights for both in vitro and in vivo research.

• Synthetic Viability in ERCC1-Deficient Lung Cancer: Role of

  2026-04-16

  This study uncovers how p53 status modulates synthetic viability in ERCC1-deficient lung cancer cells exposed to interstrand crosslinking agents. The research establishes mechanistic links between DNA repair, cell cycle arrest, and apoptosis, with implications for refining platinum-based chemotherapy biomarkers.

• Torin2 (SKU B1640): Advancing mTOR Inhibition in Cancer Rese

  2026-04-15

  This scenario-driven guide demonstrates how Torin2 (SKU B1640) addresses key experimental challenges in mTOR pathway and apoptosis assays. By integrating quantitative data, validated protocols, and real-world selection criteria, researchers gain actionable insights for robust, reproducible cancer research workflows with Torin2.

• Clathrin-Mediated Entry of Spiroplasma eriocheiris in Drosop

  2026-04-14

  Wei et al. (2019) provide direct evidence that Spiroplasma eriocheiris invades Drosophila S2 cells through clathrin-mediated endocytosis and macropinocytosis, but not caveolae-dependent pathways. The study's use of mechanistic inhibitors, including chlorpromazine, offers actionable insight for researchers dissecting host-pathogen interactions and endocytosis mechanisms in invertebrate model systems.

• Strategic Application of SAG: Translating Hedgehog Pathway I

  2026-04-13

  This thought-leadership article explores the mechanistic underpinnings and translational opportunities surrounding Smoothened Agonist (SAG), a potent Smoothened receptor agonist. We integrate key findings from cellular and preclinical studies, benchmarking SAG against macrocyclic inhibitors, and deliver actionable protocol guidance for Hedgehog pathway activation in disease models. Emphasis is placed on sex-dependent immunomodulation, myelin regeneration, and the strategic design of Hedgehog pathway activation assays. This piece uniquely bridges foundational evidence from competitive chemical probes with strategic insights for translational researchers, and positions APExBIO’s SAG as the gold standard for robust, reproducible Hedgehog pathway modulation.

• Catalpol Promotes Osteoclast Apoptosis via Sirt6-ERα-FasL Ax

  2026-04-12

  This study demonstrates that catalpol, a compound from Rehmannia glutinosa, mitigates estrogen deficiency-induced osteoporosis in ovariectomized rats by promoting osteoclast apoptosis through the Sirt6-ERα-FasL signaling pathway. These findings clarify the molecular mechanism underlying catalpol's bone-protective effects and highlight novel targets for osteoporosis intervention.

• HOXC8 Suppresses Pyroptosis via Caspase-1 Regulation in NSCL

  2026-04-12

  This study uncovers a critical mechanism by which the transcription factor HOXC8 inhibits pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by repressing caspase-1 expression. The findings highlight the potential of targeting the HOXC8–caspase-1 axis for understanding tumorigenesis and developing new approaches in inflammation research.

• Coumestrol: Phytoestrogen Estrogen Receptor Antagonist in RA

  2026-04-11

  Coumestrol stands out as a potent phytoestrogen estrogen receptor antagonist, uniquely enabling ferroptosis-based modulation of synoviocyte proliferation in rheumatoid arthritis models. This article delivers actionable protocols, troubleshooting guidance, and comparative context for deploying Coumestrol in nuclear receptor and endocrine disruption research.

• Lopinavir (ABT-378): Precision HIV Protease Inhibition in Re

  2026-04-11

  Lopinavir (ABT-378) empowers HIV researchers with exceptional potency—even in serum-rich conditions—and is robust against resistance mutations. Discover how optimized workflows using APExBIO's Lopinavir streamline protease inhibition assays, support drug resistance studies, and extend into emerging cross-pathogen antiviral research.

• Coumestrol: Nuclear Receptor Modulation and Ferroptosis i...

  2026-04-10

  Explore Coumestrol, a potent phytoestrogen estrogen receptor antagonist, and its nuanced role as a nuclear receptor modulator in autoimmune and cancer research. This article uniquely dissects Coumestrol’s mechanisms in ferroptosis and gene regulation, providing advanced insights for selective estrogen receptor modulator studies.

• Coumestrol (SKU C5832): Evidence-Based Strategies for Cel...

  2026-04-09

  This article provides an authoritative, scenario-driven guide for using Coumestrol (SKU C5832) in cell viability, cytotoxicity, and nuclear receptor assays. Drawing from quantitative literature and real-world laboratory challenges, it demonstrates how Coumestrol delivers data-backed, reproducible results for biomedical researchers and lab technicians. The article emphasizes protocol optimization, assay interpretation, and product selection, linking directly to validated resources and APExBIO’s product page.

• Coumestrol: Phytoestrogen Estrogen Receptor Antagonist fo...

  2026-04-08

  Coumestrol stands apart as a potent phytoestrogen estrogen receptor antagonist and SERM, with nanomolar inhibition of ERα and ERβ, enabling detailed interrogation of nuclear receptor pathways. Its unique dual antagonism and capacity to induce ferroptosis open new frontiers in endocrine disruption and autoimmune disease research, as highlighted by recent mechanistic studies in rheumatoid arthritis models.

• Coumestrol: Novel Mechanisms and Translational Opportunit...

  2026-04-08

  Explore how Coumestrol, a potent phytoestrogen estrogen receptor antagonist, uniquely modulates nuclear receptor signaling and induces ferroptosis in inflammatory diseases. This article offers advanced insights into Coumestrol's mechanisms and translational research potential, extending beyond conventional SERM studies.

449 records 21/30 page Previous Next First page 上5页 2122232425 下5页 Last page